Phase 2b placebo-controlled trial of M72/AS01 E candidate vaccine to prevent active tuberculosis in adults Olivier Van Der Meeren, MD,* Mark Hatherill, MD, FCPaed,* Videlis Nduba, MBChB, MPH, Robert J Wilkinson, F Med Sci, Monde Muyoyeta, MBChB, PhD, Elana Van Brakel, MBChB, MSc, Helen M Ayles, MBBS, PhD, German Henostroza, MD,§ Friedrich Thienemann, MD, Thomas J. Scriba, PhD, Andreas Diacon, MD, PhD, Gretta L. Blatner, MS, MPH, Marie-Ange Demoitié, MSc, Michele Tameris, MBChB, Mookho Malahleha, MD, MPH, James C. Innes, MBChB, MSc, Elizabeth Hellstrom, MBChB, MPhil, Neil Martinson, MBChB, MPH, Tina Singh, MD, Elaine Jacqueline Akite, MSc, Aisha Khatoon, MBBS, Anne Bollaerts, MSc, Ann M. Ginsberg, MD, PhD, Thomas G. Evans, MD,† Paul Gillard, MD,** and Dereck R. Tait, MBChB, FRCPath**al N Engl J Med. 2018 Sep 25
17
Embed
Phase 2b placebo-controlled trial of M72/AS01 candidate vaccine … · Phase 2b placebo-controlled trial of M72/AS01 E candidate vaccine to prevent active tuberculosis in adults Olivier
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Phase 2b placebo-controlled trial of M72/AS01E
candidate vaccine to prevent active tuberculosis
in adults
Olivier Van Der Meeren, MD,* Mark Hatherill, MD, FCPaed,* Videlis Nduba, MBChB, MPH, Robert J
Wilkinson, F Med Sci, Monde Muyoyeta, MBChB, PhD, Elana Van Brakel, MBChB, MSc, Helen M Ayles,
MBBS, PhD, German Henostroza, MD,§ Friedrich Thienemann, MD, Thomas J. Scriba, PhD, Andreas